tract

(redirected from Biliary tract)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia, Wikipedia.
Related to Biliary tract: gallbladder, biliary tract cancer

tract

A parcel of real estate; usually refers to a large area of land.

References in periodicals archive ?
Zonula occludens-1, occludin, and E-cadherin protein expression in biliary tract cancers.
To determine the type of trypsinogen in the serum of patients with biliary tract cancer, we developed a new sensitive time-resolved immunofluorometric assay (IFMA) for trypsin-1 in complex with AAT and studied the concentrations of this complex in sera from healthy individuals and patients with benign biliary disease, biliary tract cancer, and pancreatic cancer.
Revised estimates of diagnostic test sensitivity and specificity in suspected biliary tract disease.
Over the past century, there have been fewer accounts of this problem because of prompt and safe management of biliary tract disease.
Just as a cautionary note - seek medical advice if you have any acute or severe liver problems, such as hepatitis and biliary tract occlusion.
It has recently been shown that trypsinogen is expressed in the epithelium of benign intrahepatic bile ducts (35) and extrahepatic peribiliary glands (36), and increased concentrations of serum trypsinogen-1 and normal or slightly increased concentrations of trypsin-1-AAT have been observed in patients with benign biliary tract diseases (37).
A history of prior biliary tract disease is present in almost half of the patients with gallstone ileus.
1 treatment were observed in the majority of treated patients, thereby indicating overall survival prolongation for patients with cancers of lung, hypopharnyx, ovarian, testicular, stomach, esophageal, biliary tract and neuroendocrine tumor of skin.
The subject of the tender is the supply of direct visualization of the biliary tract involving compatible with the following components - Trolley with 3D arm incl.
subsidiary, Interpace Diagnostics, with a test currently generating approximately $10 million in revenue that is marketed for determining pancreatic cancer risk from pancreatic cysts, as well as tests in late-stage development for assessing cancer risk for Barrett's esophagus and in the biliary tract.
It is the fifth most common cancer of the gastrointestinal tract, and the most common malignancy in the biliary tract (2).
Teysuno was subsequently approved in Japan for six additional indications: for the treatment of colorectal, head and neck, non-small cell lung, metastatic breast, pancreatic and biliary tract cancers.